My recent blog on vaccines and whooping cough epidemic said that a lack of vaccination in affluent well-educated communities had the most problems with whooping cough. Mercola said that Pertussis whooping cough bacteria has mutated long ago and the vaccine has not been updated. http://articles.mercola.com/sites/articles/archive/2011/01/07/traditional-media-now-questioning-whooping-cough-vaccine.aspx
I am skeptical about this claim mainly because the CDC tries to get the latest mutation of organism. It is possible it was ignored in the Bush administration because an incompetent ran the CDC then.
I went to WebMD http://www.webmd.com which has been a reliable source of the latest information to check out Mercola. He claimed that some babies with vaccinations also got the Whooping Mutations were not mentioned.
I always wondered why babies are given the vaccines when their immune response is weak. I guess they feel it is better than nothing. For example the flu shot does not work well until the age of four to six. The Obama administration examined why the flu vaccine was not working well for seniors where 35,000 die each flu season. Seniors should all take the High Dose vaccine because our immune system is much weaker and it does not take.
One thought occurred to me. If the mother was not still protected from whooping cough, she may not pass on any immunity to her baby. I think it is not known how long the immunity of whooping cough vaccine included in Tdap vaccine for babies last, but it might wane over the years. Exposure to the flu seems, however, to protect many seniors who did not die in great numbers during the 1918 deadly Flu Epidemic which lasted research indicates killed 100 million worldwide.
If you travel to Third World countries where polio is still prevalent such as India, make sure you get the vaccine. I agree with Dr. Mercola that often doctors and experts who monitor vaccines have conflicts of interest as Mercola had for a long time. He was a paid lecturer for Big Pharma.
Jim Kawakami, Jan 7, 2010, http://jimboguy.blogspot.com
Whooping Cough Vaccine: Booster Shots Advised
Advisory Panel: More Pertussis, Meningitis Booster Shots Needed
WebMD Health News
Reviewed by Laura J. Martin, MD
Oct. 28, 2010 -- http://children.webmd.com/vaccines/news/20101028/whooping-cough-vaccine-booster-shots-advised Prompted by a recent surge in whooping cough deaths, particularly in infants, the nation's chief vaccine advisory panel says more Americans of all ages should get Tdap booster shots.
In California, 10 infant deaths from whooping cough led to a massive vaccination campaign. Now the Advisory Committee on Immunization Practices (ACIP) has broadened its whooping cough vaccine recommendations.
Whooping cough, formally known as pertussis, is included in the five-dose Dtap (diphtheria-tetanus-acellular pertussis) vaccine series routinely given to children. Nearly all kids get this vaccine. But protection wanes over the years.
About half of teens and about 6% of adults have had the Tdap (tetanus-diphtheria-acellular pertussis) vaccine. One big reason is that ACIP recommendations were confusing: they left out kids ages 7 to 10, as well as adults over age 64.
Moreover, adults who got tetanus shots usually got a tetanus-diphtheria-only vaccine and not Tdap. If they then wanted Tdap, it was unclear how long they had to wait.
The ACIP's new recommendations fix these problems:
- Any teens or adults who haven't had a Tdap shot or who don't know their vaccine history should get a Tdap shot as soon as possible.
- Adults who have not had one should get a Tdap shot regardless of how recently they had a tetanus-diphtheria booster shot.
- All kids ages 11 to 18 who had their Dtap shots as children should get a single Tdap booster instead of one tetanus-diphtheria booster.
- All adults ages 65 and older who have never had a Tdap booster should get one if they think they'll ever have close contact with an infant.
- Kids ages 7 to 10 who have not completed the full Dtap series should get a Tdap shot.
Meningitis Booster at Age 16?
By a narrow 6-5 vote, with three abstentions, the ACIP voted to recommend a second meningococcal vaccination at age 16.
Meningococcal meningitis is rare, but when it strikes, it can kill a healthy young person in less than a day. Those who survive often are horribly crippled.
The illness most often strikes young people of college age. The vaccine is recommended at age 11 to 12.
Meningococcal vaccine protection was thought to last at least 10 years. But the ACIP was shaken by new data showing that vaccine protection likely disappears after only five years.
There hasn't yet been an increase in meningococcal cases or deaths, but the majority of the ACIP did not want to wait to see if this would happen.
Those who voted against the recommendation were swayed by the high cost of vaccinating all U.S. kids -- twice -- against a relatively rare, albeit severe, disease.
Moreover, the FDA pointed out to the ACIP that existing meningococcal vaccines are not licensed for use as booster shots -- and that if the booster is recommended, studies of the booster shot's safety and effectiveness are unlikely to be performed.
But spurred on by dramatic testimony by families and individuals affected by meningococcal meningitis, the majority of the panel voted to recommend the booster shot.
The ACIP recommendations must be formally enacted by the Department of Health and Human Services (HHS). It is extremely unusual for the HHS to override the ACIP, but the close vote and the objection by the FDA makes such an action more likely.
- Baby Milestones: Is Your Baby On Track?
- Are Your Child's Vaccines Up-to-Date? Find Out Now
- Is Your Baby Getting the Right Nutrients?
- When Baby Arrives: What to Expect
View Article Sources